## **Core Concept**
Primary systemic amyloidosis, also known as AL amyloidosis, is characterized by the deposition of amyloid fibrils composed of immunoglobulin light chain fragments. This condition is often associated with plasma cell dyscrasias, such as multiple myeloma. The amyloid fibrils in AL amyloidosis are produced due to an abnormal proliferation of plasma cells that secrete excess amounts of a single type of immunoglobulin light chain.

## **Why the Correct Answer is Right**
The correct answer, **AL (A)**, refers to amyloid light chains, which are fragments of immunoglobulin light chains. In primary systemic amyloidosis, these light chains are aberrantly produced by a clone of plasma cells and are then deposited as amyloid fibrils in various tissues. The mechanism involves the misfolding of these light chains into fibrillar structures that are resistant to degradation. This process leads to organ dysfunction due to the disruption of tissue architecture and function by the amyloid deposits.

## **Why Each Wrong Option is Incorrect**
- **Option B: AA**: This refers to amyloid-associated protein, which is seen in secondary amyloidosis (AA amyloidosis). This type of amyloidosis occurs in response to chronic inflammation or infection, leading to the production of serum amyloid A (SAA) protein, which is then converted into amyloid fibrils. This is not related to primary systemic amyloidosis.
- **Option C: ATTR**: This stands for transthyretin amyloidosis, a form of amyloidosis caused by the deposition of transthyretin (a transport protein) variants. While this is a type of systemic amyloidosis, it is distinct from primary systemic amyloidosis in terms of the protein involved and the underlying cause.
- **Option D: Abeta**: This refers to amyloid-beta peptides, which are associated with Alzheimer's disease. This form of amyloidosis is confined to the brain and is not related to primary systemic amyloidosis.

## **Clinical Pearl / High-Yield Fact**
A key clinical pearl is that primary systemic amyloidosis (AL amyloidosis) often presents with nephrotic syndrome, heart failure, and neuropathy. The diagnosis involves demonstrating the presence of amyloid deposits in tissues and identifying the specific type of amyloid protein involved, usually through biopsy and immunohistochemistry or serum/urine protein electrophoresis.

## **Correct Answer: A. AL.**